This exploration was completed To judge the prospective of the CPPs with tumor-concentrating on properties to deliver a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-concentrating on peptide, T22, fused with cytotoxic peptide PE24, as a novel therapeutic approach for CXCR4+ HCC cells. T22 was picked because the https://charlesj429fms5.ktwiki.com/user